
Midatech Pharma plc MTP
Annual report 2024
added 12-13-2025
Midatech Pharma plc DPO Ratio 2011-2025 | MTP
Annual DPO Ratio Midatech Pharma plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 162 | 11.9 K | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.9 K | 162 | 6.04 K |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 25.27 | -2.43 % | $ 1.22 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
23 | $ 4.75 | 1.61 % | $ 788 M | ||
|
Aclaris Therapeutics
ACRS
|
887 | $ 3.26 | -3.12 % | $ 252 M | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Kamada Ltd.
KMDA
|
106 | $ 7.03 | 0.14 % | $ 260 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
193 | $ 0.91 | -5.01 % | $ 18.7 M | ||
|
AstraZeneca PLC
AZN
|
265 | $ 89.78 | -0.57 % | $ 96.9 B | ||
|
Anika Therapeutics
ANIK
|
54.4 | $ 9.57 | 0.84 % | $ 140 M | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | ||
|
Benitec Biopharma
BNTC
|
-556 | $ 12.05 | -7.06 % | $ 496 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.34 | 2.59 % | $ 14.7 M | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
2.41 K | - | -19.68 % | $ 18.4 M | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
Aptorum Group Limited
APM
|
405 | $ 1.29 | -3.01 % | $ 7.03 M | ||
|
Baudax Bio
BXRX
|
140 | - | 0.59 % | $ 63 K | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Catalyst Biosciences
CBIO
|
18.8 | $ 14.01 | -8.49 % | $ 922 M | ||
|
ChromaDex Corporation
CDXC
|
90.1 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
29.9 | $ 566.18 | -2.56 % | $ 42.9 B | ||
|
Cerus Corporation
CERS
|
242 | $ 2.16 | 0.47 % | $ 399 M | ||
|
Caladrius Biosciences
CLBS
|
51.2 | - | -16.75 % | $ 25.8 M | ||
|
Clovis Oncology
CLVS
|
236 | - | -7.23 % | $ 13 M | ||
|
Biogen
BIIB
|
65.4 | $ 174.42 | 1.11 % | $ 25.4 B | ||
|
Celldex Therapeutics
CLDX
|
6.17 K | $ 27.36 | -2.09 % | $ 1.76 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.2 K | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
199 | $ 11.54 | 0.87 % | $ 746 M |